Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 6 de 6
Filtrer
1.
Infect Dis Now ; 52(2): 82-86, 2022 Mar.
Article de Anglais | MEDLINE | ID: mdl-34091093

RÉSUMÉ

OBJECTIVES: To describe the epidemiology of Klebsiella spp. meningitis in France with respect to clinical and bacteriological data. METHODS: We performed a four-year multicenter, retrospective, observational study. The primary objective was to provide a clinical description of patients with Klebsiella spp. meningitis. Secondary objectives were to compare community-acquired meningitis and healthcare-associated meningitis and to analyze factors associated with mortality. RESULTS: We enrolled 131 patients with Klebsiella spp. meningitis. Eighty-two (62.6%) infections were reported following neurosurgery. Twenty-eight strains (21.4%) were resistant to third-generation cephalosporins (3GC). The median [IQR] cellularity was 980/mm3 [116-5550], the median protein level was 5.67 [1.62-9] g/L and the median CSF glucose level was 2.5 [0-3.4] mmol/L. The in-hospital mortality rate was 23.6%. Community-acquired meningitis isolates were more frequently susceptible to 3GC than isolates from healthcare-associated meningitis (89.2% versus 72%; P=0.04). Comorbidities reported for patients with community-acquired meningitis were mainly diabetes mellitus and liver cirrhosis. In multivariate analysis, focal neurological disorder at the time of diagnosis was the only factor associated with in-hospital mortality (P=0.01). CONCLUSIONS: Purulent meningitis caused by Klebsiella spp. needs to be considered in patients with community-acquired meningitis and preexisting conditions, as well as in case of meningitis following neurosurgical procedures.


Sujet(s)
Infections à Klebsiella , Méningite bactérienne , France/épidémiologie , Humains , Klebsiella , Infections à Klebsiella/complications , Infections à Klebsiella/traitement médicamenteux , Infections à Klebsiella/épidémiologie , Méningite bactérienne/complications , Méningite bactérienne/traitement médicamenteux , Méningite bactérienne/épidémiologie , Études rétrospectives
2.
Med Mal Infect ; 50(8): 715-722, 2020 Nov.
Article de Anglais | MEDLINE | ID: mdl-32113869

RÉSUMÉ

OBJECTIVE: This 2018 report of Healthcare-Associated Infections Early Warning and Response System (HAI-EWRS) notifications of carbapenemase-producing Enterobacteriaceae (CPE) or glycopeptide-resistant Enterococcus faecium (GRE), and of strains analysed by the National Reference Center for anti-microbial resistance (NRC) aimed to describe the epidemiology of emerging extensively drug-resistant bacteria (eXDR) in France and control measures implemented in hospital settings. PATIENTS AND METHODS: All HAI-EWRS notifications of eXDR received at the national level and all eXDR strains received at the NRC between January 1, 2018 and January 31, 2018 were analysed. Variables analysed were number of cases, number of strains, resistance mechanism, sample type, link with a foreign country, and control measures implemented. RESULTS: In 2018, 1704 CPE notifications and 315 GRE notifications were reported in France, with an increasing trend since 2012 (×6 for CPE, ×3 for GRE), from respectively 364 and 155 hospitals (+66% for CPE, +57% for GRE since 2012). eXDR strains were mainly isolated from rectal screening swabs. Notifications with patients receiving standard precautions were more often associated with outbreaks than notifications with patients receiving contact precautions at admission. NRC received 2674 CPE strains and 775 GRE strains in 2018 (×8.3 and ×2.8 compared with 2012). CONCLUSION: The increasing annual number of eXDR notifications and eXDR strains received by the NRC is multifactorial but reflects a worrying spread of eXDR in France. The number of infections remains low, but this article shows that existing recommendations are not fully implemented.


Sujet(s)
Enterobacteriaceae résistantes aux carbapénèmes , Infection croisée , Infections à Enterobacteriaceae , Enterococcus faecium , Préparations pharmaceutiques , Antibactériens/pharmacologie , Antibactériens/usage thérapeutique , Infection croisée/traitement médicamenteux , Infection croisée/épidémiologie , Infections à Enterobacteriaceae/traitement médicamenteux , France/épidémiologie , Humains , Prévention des infections
4.
Clin Microbiol Infect ; 20(4): 340-4, 2014 Apr.
Article de Anglais | MEDLINE | ID: mdl-23889766

RÉSUMÉ

The biochemical-based Carba NP test has been evaluated to detect carbapenemase-producing Enterobacteriaceae (n = 193) directly from spiked blood cultures. It was able to rapidly detect KPC (n = 50), IMP (n = 27), VIM (n = 37), NDM (n = 33) and OXA-48-like producers (n = 46) with sensitivity and specificity of 97.9% and 100%, respectively. This cost-effective technique may be implemented in any microbiology laboratory and offers a reliable test for an early identification of carbapenemase-producing Enterobacteriaceae directly from blood culture that could be useful for the management of infected patients.


Sujet(s)
Bactériémie/microbiologie , Protéines bactériennes/analyse , Techniques bactériologiques/méthodes , Sang/microbiologie , Infections à Enterobacteriaceae/microbiologie , Enterobacteriaceae/enzymologie , Enterobacteriaceae/isolement et purification , bêta-Lactamases/analyse , Techniques bactériologiques/économie , Analyse coût-bénéfice , Humains , Sensibilité et spécificité
5.
Clin Microbiol Infect ; 18(5): E144-8, 2012 May.
Article de Anglais | MEDLINE | ID: mdl-22404169

RÉSUMÉ

Twenty-two carbapenem-resistant enterobacterial isolates were recovered from patients hospitalized between October 2010 and March 2011 at the Royal Hospital of Muscat, Sultanate of Oman. Eleven NDM-1, five OXA-48 and one NDM-1 plus OXA-181 producers of diverse ST types were recovered from clinical samples. All carbapenemase genes were located on self-conjugative plasmids and were nearly always associated with other resistance determinants, including extended-spectrum ß-lactamases and the ArmA methylase encoding resistance to aminoglycosides. This work highlights the dissemination of NDM-1 and OXA-48-type producers in the Middle East.


Sujet(s)
Protéines bactériennes/biosynthèse , Carbapénèmes/pharmacologie , Infections à Enterobacteriaceae/microbiologie , Enterobacteriaceae/enzymologie , bêta-Lactamases/biosynthèse , Antibactériens/pharmacologie , ADN bactérien/génétique , Multirésistance bactérienne aux médicaments , Enterobacteriaceae/classification , Enterobacteriaceae/effets des médicaments et des substances chimiques , Infections à Enterobacteriaceae/épidémiologie , Humains , Tests de sensibilité microbienne , Oman/épidémiologie
6.
Ann Biol Clin (Paris) ; 62(6): 707-11, 2004.
Article de Français | MEDLINE | ID: mdl-15563431

RÉSUMÉ

Incidence of cardiovascular events is higher in hemodialysis (HD) patients than in general population. Oxidative stress represents a major specific risk factor of accelerated atheroma particularly in association with inflammation and malnutrition. The aim of our study is to evaluate a simple test of lipid peroxidation measurement using the "Free Oxygen Radical Monitor" (FORM) (Callegari, Italy). The results obtained in HD patients were compared to standard oxidative stress markers, such as thiobarbituric acid reacting substances, carbonyls and vitamin E in plasma, and glutathione, oxidized to reduced form ratio, in erythrocytes. In conclusion, the FORM system presents no sufficient sensibility and specificity to determine oxidative stress in HD patients.


Sujet(s)
Peroxydation lipidique , Stress oxydatif , Oxygène/sang , Dialyse rénale , Femelle , Radicaux libres/sang , Humains , Mâle , Adulte d'âge moyen , Facteurs temps
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...